Related Experiment Video
Updated: May 24, 2026
04:36
Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
L carnitine in hemodialysis patients
Lorenzo A Calò1, Ugo Vertolli, Paul A Davis
1Department of Medicine, Clinica Medica 4, University of Padova, Padova, Italy. renzcalo@unipd.it
Hemodialysis International. International Symposium on Home Hemodialysis
|February 25, 2012
Summary
Carnitine deficiency is common in hemodialysis patients, potentially causing anemia and cardiovascular issues. While carnitine treatment may offer benefits, more research is needed to confirm its effectiveness and guide widespread use.
Area of Science:
- Nephrology
- Biochemistry
- Metabolism
Background:
- Carnitine (3-hydroxy-4-trimethylaminobutyrate) is vital for mitochondrial fatty acid oxidation.
- Hemodialysis patients often exhibit carnitine deficiency, exacerbated by uremia and dialysis procedures.
- This deficiency is linked to clinical issues like anemia, cardiovascular disease, and muscle weakness.
Purpose of the Study:
- To review clinical aspects of carnitine deficiency in chronic renal failure.
- To evaluate the effects of carnitine treatment in these patients.
- To identify areas requiring further research, particularly randomized trials.
Main Methods:
- Systematic review of existing studies on carnitine deficiency in chronic renal failure.
- Analysis of studies investigating carnitine supplementation in hemodialysis patients.
- Examination of clinical outcomes related to carnitine levels and treatment.
Main Results:
- Carnitine deficiency is prevalent in hemodialysis patients, contributing to various clinical problems.
- Preliminary data suggest potential benefits of carnitine treatment for renal anemia, insulin sensitivity, and protein catabolism.
- Reported clinical responses to carnitine therapy are heterogeneous among dialysis patients.
Conclusions:
- Carnitine deficiency is a significant concern in chronic renal failure and hemodialysis.
- While carnitine supplementation shows promise for specific conditions, its widespread use is currently limited.
- Large-scale, well-designed randomized clinical trials are essential to establish definitive evidence for carnitine's efficacy in dialysis patients.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Hemodialysis III: Nursing Management
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...